Cytogenetic damage measured in human sperm following cancer chemotherapy.
Germ-line cytogenetic damage is well documented in laboratory animals exposed to anti-cancer agents, but has been harder to verify in the human. This paper reviews published studies demonstrating cytogenetic damage in human sperm following exposure to anti-cancer chemicals, as measured by the human-sperm/ hamster-egg cytogenetic technique and fluorescence in situ hybridization. These two assays have provided important information on one step in the pathway leading to induced, transmissible germ line damage in the human. By way of introduction, a short review of the traditional human endpoints used to address the question of induced, transmissible genetic damage in human germ cells (mutation epidemiology) related to anti-cancer chemicals is presented.
Robbins
W A
WA
School of Public Health, University of North Carolina at Chapel Hill, USA. robbins2@niehs.nih.gov
D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D002875:Chromosomes / Q000187:drug effects; D006224:Cricetinae; D018095:Germ-Line Mutation; D006801:Humans; D017404:In Situ Hybridization, Fluorescence / Q000379:methods; D008297:Male; D009152:Mutagenicity Tests / Q000379:methods*; D009369:Neoplasms / Q000188:drug therapy; D010063:Ovum / Q000187:drug effects; D013094:Spermatozoa / Q000187:drug effects*
D000970:Antineoplastic Agents